Form 4: Concentra Group Holdings Executive Receives 180,000 Shares of Restricted Stock

Matthew T. DiCanio, President & Chief Financial Officer of Concentra Group Holdings Parent, Inc., was granted 180,000 shares of restricted stock on November 26, 2024.

Summary

• Matthew T. DiCanio, President & Chief Financial Officer of Concentra Group Holdings Parent, Inc., received 180,000 shares of restricted stock.
• The grant occurred on November 26, 2024.
• The restricted stock will vest in equal annual installments over four years.
• This transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of executive compensation, which is generally viewed positively as it aligns executive interests with company performance. There are no negative implications.

Positives

• The grant of restricted stock aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and contribution from the executive.

Industry Context

The granting of restricted stock is a common practice in corporate compensation to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Restricted stock grants are a standard form of executive compensation across various industries.
• The four-year vesting period is a typical timeframe for such grants, aligning with long-term performance goals.
• Many companies in the healthcare services sector, such as HCA Healthcare and Tenet Healthcare, use similar equity-based compensation strategies.

Stakeholder Impact

• Shareholders may view the stock grant positively as it incentivizes management to improve company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

restricted stock, executive compensation, Form 4, insider trading, stock grant, vesting, Concentra Group Holdings